Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19: Overview
This document will help manufacturers prepare a submission for a notice of compliance for a COVID-19 drug under the Regulations. It also outlines the process for meeting the post-market regulatory requirements.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2021-07-29
Data overview
- Formats
- HTML
- File languages
- English, French